Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers Stock's 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started
03:00pm, Thursday, 08'th May 2025
If short sellers were hoping for a flop from Hims & Hers Health Inc. HIMS, they may want to check their risk management settings. The telehealth disruptor dropped first-quarter earnings after the bell
Hims & Hers: The Road To Blue Chip Status
09:45am, Thursday, 08'th May 2025
Personalized subscribers grew 136% YoY, reflecting a fundamental shift towards precision medicine. Despite declining gross margins, HIMS achieved 13pp of operating leverage in Q1. This is by far HIMS'
Hims & Hers Soars Again--Explosive Growth Meets Lofty Expectations
07:57am, Thursday, 08'th May 2025
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo Nordisk partnership. Despite trading at a high valuation, technical indicato
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced its intention to offer, subject to market and other conditions, $450 milli
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer
06:50am, Thursday, 08'th May 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Mo Elshenawy, a proven technology executive with dee
Hims & Hers Has a Superpower in Healthcare
06:30am, Thursday, 08'th May 2025
Hims & Hers (HIMS 5.21%) CEO Andrew Dudum isn't interested in taking insurance onto his platform, and that shows how disruptive the company could be. This could be the next great growth stock if Dudum
Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy?
05:05am, Thursday, 08'th May 2025
Following the company's first-quarter earnings report, shares of Hims & Hers Health (HIMS 5.21%) opened the following day considerably lower, only to sprint higher once trading began. This action is j
Hims & Hers: 2030 Guidance Indicates Big Upside
10:16pm, Wednesday, 07'th May 2025
Management's 2030 guidance includes $6.5 billion in revenue and $1.3 billion in adjusted EBITDA, focusing on personalized healthcare and geographic expansion. Anticipating management's guidance for 20
Surging Earnings Estimates Signal Upside for Hims & Hers Health (HIMS) Stock
01:20pm, Wednesday, 07'th May 2025
Hims & Hers Health (HIMS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Hims & Hers: Short Squeeze Or Strong Fundamentals? (Rating Downgrade)
11:18am, Wednesday, 07'th May 2025
Hims & Hers Health, Inc. Q1 results beat the Street's expectations, as I anticipated in February. The company reaffirmed FY 2025 guidance and increased the EBITDA range for the year. That said, I beli
Hims & Hers Shows It's More Than Just GLP-1 Drugs
08:54am, Wednesday, 07'th May 2025
Hims & Hers Health (HIMS) released first-quarter earnings after the closing bell on Monday and saw shares surge on the robust numbers.
Hims & Hers Health: Healthcare Disruptor Building A Durable Moat (Initiate With Buy)
08:23am, Wednesday, 07'th May 2025
Hims & Hers Health reported strong Q1 '25 earnings, with 111% YoY sales growth and 38% subscriber growth. The company boasts over a 70% gross margin, 90% recurring revenue, and a compelling flywheel e
Hims & Hers Jumps 18.2% on Incredible 111% Revenue Growth
07:30am, Wednesday, 07'th May 2025
Hims & Hers (HIMS 19.03%) stock soared 18.2% in trading on Tuesday after the company reported first-quarter revenue growth of 111% and an increase in 2025 guidance. The results were phenomenal and a s
Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped
02:32pm, Tuesday, 06'th May 2025
Investors are buying Hims & Hers Health (HIMS 19.77%) stock hand over fist after the mail-order drugs company reported an earnings miss but a sales beat last night. But they're selling off shares of E
Options Bulls Blast Surging Telehealth Stock After Earnings
01:56pm, Tuesday, 06'th May 2025
Hims & Hers Health Inc (NYSE:HIMS) beat top- and bottom-line estimates for the first quarter, with net profits seeing a 300% jump.
